BDBM250033 US10005782, Compound 155::US9447106, 155::US9556188, Compound 155

SMILES: NC(=O)c1c2NCCC(c3ccccc3NC(=O)C=C)n2nc1-c1cccc(Cl)c1

InChI Key: InChIKey=IMCJMNVMHGKSFH-UHFFFAOYSA-N

Data: 3 IC50

Find this compound or compounds like it in BindingDB or PDB:

Substructure Similarity at least:  must be >=0.5 Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 250033   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Tyrosine-protein kinase BTK (Homo sapiens (Human))	BDBM250033 (US10005782, Compound 155 | US9447106, 155 | US9556...) Show SMILES NC(=O)c1c2NCCC(c3ccccc3NC(=O)C=C)n2nc1-c1cccc(Cl)c1 Show InChI InChI=1S/C22H20ClN5O2/c1-2-18(29)26-16-9-4-3-8-15(16)17-10-11-25-22-19(21(24)30)20(27-28(17)22)13-6-5-7-14(23)12-13/h2-9,12,17,25H,1,10-11H2,(H2,24,30)(H,26,29)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	0.960	n/a	n/a	n/a	n/a	n/a	25
BeiGene, Ltd. US Patent					Assay Description Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfe...				US Patent US9447106 (2016) BindingDB Entry DOI: 10.7270/Q21Z439C
					More data for this Ligand-Target Pair
Tyrosine-protein kinase BTK (Homo sapiens (Human))	BDBM250033 (US10005782, Compound 155 | US9447106, 155 | US9556...) Show SMILES NC(=O)c1c2NCCC(c3ccccc3NC(=O)C=C)n2nc1-c1cccc(Cl)c1 Show InChI InChI=1S/C22H20ClN5O2/c1-2-18(29)26-16-9-4-3-8-15(16)17-10-11-25-22-19(21(24)30)20(27-28(17)22)13-6-5-7-14(23)12-13/h2-9,12,17,25H,1,10-11H2,(H2,24,30)(H,26,29)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	0.960	n/a	n/a	n/a	n/a	n/a	n/a
Wyeth Research					Assay Description Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfe...				Bioorg Med Chem 17: 7755-68 (2009) BindingDB Entry DOI: 10.7270/Q29889BD
					More data for this Ligand-Target Pair
Tyrosine-protein kinase BTK (Homo sapiens (Human))	BDBM250033 (US10005782, Compound 155 | US9447106, 155 | US9556...) Show SMILES NC(=O)c1c2NCCC(c3ccccc3NC(=O)C=C)n2nc1-c1cccc(Cl)c1 Show InChI InChI=1S/C22H20ClN5O2/c1-2-18(29)26-16-9-4-3-8-15(16)17-10-11-25-22-19(21(24)30)20(27-28(17)22)13-6-5-7-14(23)12-13/h2-9,12,17,25H,1,10-11H2,(H2,24,30)(H,26,29)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	0.960	n/a	n/a	n/a	n/a	n/a	25
BeiGene, Ltd. US Patent					Assay Description Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfe...				US Patent US9556188 (2017) BindingDB Entry DOI: 10.7270/Q26Q2082
					More data for this Ligand-Target Pair